• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/13

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

13 Cards in this Set

  • Front
  • Back
Bacteriology
Aerobic, non-spore forming, gram-negative rod, slightly curved
Motile
Facultative anaerobe
Structure
Outer cell membrane - LPS and porin proteins
Pili, flagellum, alginate
Extracellular products - Exotoxin A
enters via endocytosis --> inactivation of EF-2 by ADP ribosylation --> protein synthesis and cell death
Cytotoxic, not systemic
Extracellular products - Exoenzyme S
ADP-ribosylates several intracellular proteins, including the cytoskeleton filament vimentin
Extracellular products - Elastase
Breaks down human components
Epidemiology
Grows in humidfiers
High risk - neonates IVDA, immunocompromised, burn patients, CF pts
Virulence factors
Exotoxin A
Exotoxin S
Elastase
Culture & Biochemistry
Blood agar - hemolytic
Grows at 42C
Fruity odor
Oxidase +, produces pyocyanin
Resistance MOA
Porin proteins - restrict antibiotic entry
Mutation in target molecule

Resistant Abx: penicillin, ampicillin, cephalothin, tetracycline, chloramphenicol, sulfonamides, and the earlier generations of aminoglycosides
Treatment - b-lactam antibiotics (selective)
3rd generation cephalosporins (ceftazidime, cefepime, cefoperazone); Carbapenem (imipenem, meropenem); Monobactams (aztreonam)
Treatment - Newer aminoglycosides
Gentamicin
tobramycin
amikacin
Treatment - Quinolones
Ciprofloxacin
Prevention
Vaccine for burn, CF, immunocompromised patients contains somatic antigens